Rating History for Medicenna Therapeutics (MDNA) by Oppenheimer

More Stocks Rated by Oppenheimer | Latest Ratings for MDNA
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/10/2022 Matthew Biegler Maintain Outperform
(N/A)		 8.00
(10.00)		  
 		   Details